KUKJEON PHARMACEUTICAL Co., Ltd (KOSDAQ:307750)

Market Cap	193.62B
Revenue (ttm)	135.44B
Net Income (ttm)	1.44B
Shares Out	49.97M
EPS (ttm)	29.35
PE Ratio	132.02
Forward PE	n/a
Dividend	10.00 (0.26%)
Ex-Dividend Date	n/a

Volume	157,173
Average Volume	778,784
Open	3,870.00
Previous Close	3,870.00
Day's Range	3,855.00 - 3,940.00
52-Week Range	2,780.00 - 5,290.00
Beta	-0.89
RSI	44.91
Earnings Date	Aug 14, 2025

About KUKJEON PHARMACEUTICAL

KUKJEON PHARMACEUTICAL Co., Ltd operates as a chemical total solutions provider in South Korea. It provides various chemical-based products and services; and after-sales services, such as research and development, production, quality control, and DMF services. The company manufactures active pharmaceutical ingredients; and offers molecular design and technical support. It develops electronic materials, such as antistatic agents, monomers and polymers with low dielectric constant, and UV curing agents; low-resistance electrolyte, phosphine, sila...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1972
• Employees: 172
• Stock Exchange: KOSDAQ
• Ticker Symbol: 307750

Financial Performance

In 2024, KUKJEON PHARMACEUTICAL's revenue was 136.47 billion, an increase of 11.86% compared to the previous year's 122.00 billion. Earnings were 1.74 billion, a decrease of -64.01%.